Cate Speake Selected Research

Cate Speake Research Topics

Disease

51	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2024 - 05/2014
13	Disease Progression 05/2024 - 01/2018
6	Inflammation (Inflammations) 05/2023 - 04/2013
5	COVID-19 05/2023 - 01/2021
4	Type 2 Diabetes Mellitus (MODY) 01/2019 - 01/2017
3	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 05/2014
3	Infections 03/2022 - 01/2021
2	Human Influenza (Influenza) 07/2023 - 04/2013
2	Critical Illness (Critically Ill) 05/2023 - 01/2021
2	Pancreatitis 11/2022 - 01/2022
2	Hepatitis D 03/2022 - 01/2022
2	Hyperglycemia 01/2022 - 01/2019
2	Malaria 01/2016 - 01/2009
2	Neoplasms (Cancer) 01/2015 - 01/2014
1	Polydipsia 07/2023
1	Hypertension (High Blood Pressure) 07/2023
1	Polyuria 07/2023
1	Fibrosis (Cirrhosis) 05/2023
1	Rheumatoid Arthritis 01/2023
1	Myocarditis (Carditis) 01/2023
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2023
1	Down Syndrome (Down's Syndrome) 12/2022
1	Pain (Aches) 11/2022
1	Insulin Resistance 01/2022
1	Multiple Sclerosis 01/2022
1	Congenital Hyperinsulinism 01/2020
1	Obesity 01/2019
1	Lupus Nephritis 01/2017
1	Melanoma (Melanoma, Malignant) 01/2014

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2015
14	AutoantibodiesIBA 05/2024 - 01/2018
12	Insulin (Novolin)FDA Link 10/2023 - 01/2018
10	AntigensIBA 10/2023 - 01/2016
8	EpitopesIBA 07/2023 - 01/2018
6	C-PeptideIBA 05/2024 - 11/2018
6	Proteins (Proteins, Gene)FDA Link 05/2023 - 01/2009
5	CytokinesIBA 12/2022 - 01/2020
5	ProinsulinIBA 01/2022 - 12/2018
4	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2017
3	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 01/2022
3	AutoantigensIBA 07/2023 - 01/2020
3	VaccinesIBA 01/2023 - 01/2022
3	COVID-19 VaccinesIBA 01/2023 - 01/2022
3	mRNA VaccinesIBA 01/2023 - 01/2022
3	Messenger RNA (mRNA)IBA 01/2023 - 01/2023
3	Interleukin-6 (Interleukin 6)IBA 12/2022 - 01/2021
3	InterferonsIBA 12/2022 - 04/2013
2	Protein Isoforms (Isoforms)IBA 01/2023 - 01/2021
2	Neutralizing AntibodiesIBA 03/2022 - 01/2022
2	AntibodiesIBA 03/2022 - 01/2022
2	Peptides (Polypeptides)IBA 01/2022 - 01/2020
2	Cell-Free Nucleic AcidsIBA 01/2020 - 01/2020
2	Hyaluronic Acid (Hyaluronan)IBA 01/2020 - 01/2019
2	Abatacept (Orencia)FDA Link 01/2019 - 11/2018
1	teplizumabIBA 01/2024
1	Alefacept (Amevive)FDA Link 11/2023
1	HLA-DR alpha-ChainsIBA 07/2023
1	Immunodominant EpitopesIBA 07/2023
1	preproinsulinIBA 07/2023
1	Blood Glucose (Blood Sugar)IBA 07/2023
1	Hemoglobins (Hemoglobin)IBA 07/2023
1	Blood Proteins (Serum Proteins)IBA 05/2023
1	golimumab FDA Link 01/2023
1	siltuximabIBA 11/2022
1	tocilizumab (atlizumab)FDA Link 11/2022
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 11/2022
1	Interleukin-8 (Interleukin 8)IBA 11/2022
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 11/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2022
1	Angiopoietin-2IBA 11/2022
1	ResistinIBA 11/2022
1	GlucokinaseIBA 01/2022
1	anti-GAD65 autoantibodyIBA 01/2022
1	HLA-DR3 Antigen (HLA DR3 Antigen)IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2021
1	Viral RNAIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Interleukin-1 (Interleukin 1)IBA 01/2020
1	staphylococcal enterotoxin BIBA 01/2020
1	Insulin-Like PeptidesIBA 01/2020
1	GlycosaminoglycansIBA 01/2019
1	HLA-DR Antigens (HLA-DR)IBA 12/2018
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2018
1	Amyloid (Amyloid Fibrils)IBA 01/2017
1	Interleukin-2 (IL2)IBA 01/2017
1	Combined VaccinesIBA 01/2016
1	Complement C4 (Complement Component 4)IBA 05/2014
1	ElementsIBA 05/2014
1	HLA-DQB1 antigen (HLA DQB1)IBA 05/2014
1	Complement System Proteins (Complement)IBA 05/2014
1	Interferon Type IIBA 01/2014
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 04/2013
1	ProteomeIBA 01/2009

Therapy/Procedure

14	Therapeutics 01/2024 - 01/2019
4	Immunotherapy 01/2023 - 01/2014
2	Precision Medicine 10/2023 - 04/2023
1	Glycemic Control 01/2019
1	Immunomodulation 01/2019